Proof The Bible Is True

A new study has found a link between the active ingredient in popular weight loss and diabetes drugs like Ozempic and Wegovy and a 45% higher likelihood of suicidal ideation.

 

It’s a significant finding that prompted the authors of the study to write that it “warrants urgent clarification.” The study, which was published in the journal JAMA Network Open, was based on an analysis of the World Health Organization’s adverse drug events database. To reach their conclusion, they compared reporting rates of suicidal ideation and other suicide-related behaviors for individuals taking semaglutide as well as another weight loss medication that falls into the same class of drugs, liraglutide.

 

When they compared these suicidal ideation rates to those of all the other drugs listed in the WHO database, they found a shocking 45% higher likelihood of suicidal ideation linked to semaglutide. Among those who reported suicidal effects from taking semaglutide, 86% experienced suicidal ideation, while 6.5% attempted suicide and another 6.5% attempted to overdose. Sadly, discontinuing the drug only caused suicidal ideation to go away 62% of the time.

 

Read More: DYING TO LOSE WEIGHT: Study finds alarming link between popular weight loss drugs and increase in suicidality